Plasma fibrinogen in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction

Coronary Artery Disease

Volumn 12, Issue 3, 2001, Pages 157-165

  Tataru, MiraChristine ^a,b,f   Schulte, Helmut ^c   Von Eckardstein, Arnold ^c   Heinrich, Jürgen ^d   Assmann, Gerd ^c   Koehler, Ekkehart ^e  

^a Abteilung Kardiologie   (Germany)

^b Rhon Klinikum AG   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d STÄDTISCHES KLINIKUM SOLINGEN   (Germany)

^e Klinikum Meiningen   (Germany)

^f Abteilung Kardiologie   (Germany)

Author keywords

Arteriosclerosis; Coronary artery disease; Fibrinogen; Myocardial infarction; Risk factors

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ANGIOGRAPHY; ARTERIOSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART INFARCTION; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PLASMA VISCOSITY; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE AGGREGATION;

EID: 0035036599     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200105000-00001     Document Type: Article

References (66)

1. Recent progress in the pathophysiology of fibrinogen
2. Fibrinogen and cardiovascular disease: Historical introduction
3. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study
4. Haemostatic factors and prevalent coronary heart disease; the FINRISK haemostasis study
5. Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease. The Caerphilly and Speedwell Studies
6. Fibrinogen, viscosity and white blood cell count are maior risk factors for ischemic heart disease: The Caerphilly and Speedwell collaborative heart disease studies
7. Evidence for time-dependent activation of monocytes in the systemic circulation in unstable angina but not in acute myocardial infarction or in stable angina
8. Platelet function and plasma fibrinogen and their relations to gender, smoking habits, obesity and beta-blocker treatment in young survivors of myocardial infarction
9. Impaired fibrinolysis in coronary artery disease
10. The role of β-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden
11. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction
12. Haemostatic function in myocardial infarction
13. Haemostasefaktoren und koronare Herzkrankheit. Fibrinogen, Faktor VII und Plasminogen-Inhibitor
14. Lipids, lipoproteins, fibrinogen and fibrinolytic activity in angiographically assessed coronary heart disease
15. Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina
16. Coronary artery disease and haemostatic variables in heterozygous familial hypercholesterolaemia
17. Fibrinogen after coronary angioplasty as a risk factor for restenosis
18. Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting
19. Therapeutic interventions to lower plasma fibrinogen concentration
20. Blood pressure, cigarette smoking and heart attack in the WHO co-operative trial of clofibrate
21. Fibrinogen in ischaemic heart disease
22. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report of from the committee of principal investigators
23. Fibrinogen as a cardiovascular risk factor-interrelationship with infections and inflammation
24. Relation of fibrinogen to presence and severity of coronary artery disease is independent of other coexisting heart disease
25. ECAT angina pectoris study: Baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography
26. Fibrinogen und leukozytenzahl bei koronarer herzkrankheit. Korrelationen zum angiographischen und klinischen schweregrad
27. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens
28. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain
29. Fibrinogen and risk of cardiovascular disease. The Framingham Study
30. Epidemiology of fibrinogen
31. β-Fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery, disease in patients with myocardial infarction. The ECTIM study. Étude Cas-Temoins sur l'Infarctus du Myocarde
32. Cigarette smoking and hemostatic function
33. Plasma fibrinogen: Levels and correlates in young adults. The Coronary Artery Risk Development in Young Adults (CARDIA) Study
34. Genetic regulation of fibrinogen
35. Relationship of cigarette smoking to the severity of coronary and thoracic aortic atherosclerosis
36. An update on coronary risk factors
37. Ethnic differences in risk markers for heart disease in Bradford and implications for preventive strategies
38. Temperature and risk factors for ischaemic heart disease in the Caerphilly prospective study
39. The epidemiology of atheroma, thrombosis and ischaemic heart disease
40. Seasonal variations in fibrinogen concentrations among elderly people
41. Influence of weather and climate on the fibrinogen content of human blood
42. Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: Winter infections and death from cardiovascular disease
43. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIb Trial)
44. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature
45. Fibrinogen and factor VII in the prediction of coronary risk: Results from the PROCAM study in healthy men
46. Hemostatic factors and the risk of myocardial infarction
47. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
48. Association between rheology and components of lipoproteins in human blood. Results from the MONICA project
49. C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris
50. Update on fibrinogen as a cardiovascular risk factor
51. Plasma fibrinogen and coronary risk factors: The Scottish Heart Health Study
52. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
53. Plasma fibrinogen: A major coronary risk factor
54. Fibrinogen as a risk factor for stroke and myocardial infarction
55. Determinants of lipoprotein(a) levels in a middle-aged working population
56. Impact of polymorphisms in the alpha- and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients
57. Close relation between lipoprotein(a) levels and atherothrombotic disease in Japanese subjects > 75 years of age
58. Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes